{"disease":{"id":"minimal-change-disease","name":"minimal change disease"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06065852","title":"National Registry of Rare Kidney Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":35000,"lead_sponsor_name":"UK Kidney Association","has_results":false},{"nct_id":"NCT03929887","title":"KOrea Renal Biobank NEtwoRk System TOward NExt-generation Analysis","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT03949972","title":"The FOrMe Registry (The German Focal Segmental Glomerulosclerosis and Minimal Change Disease Registry)","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Prof. Dr. Paul Brinkkoetter","has_results":false},{"nct_id":"NCT04571658","title":"NEPTUNE Match Study","phase":"NA","overall_status":"RECRUITING","enrollment_count":375,"lead_sponsor_name":"University of Michigan","has_results":false},{"nct_id":"NCT07499700","title":"A Clinical Study of BAT4406F Injection in Patients With Minimal Change Disease/Focal Segmental Glomerulosclerosis","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":192,"lead_sponsor_name":"Bio-Thera Solutions","has_results":false},{"nct_id":"NCT05505500","title":"Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome.","phase":"","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"University of Michigan","has_results":false},{"nct_id":"NCT06315504","title":"Circulating Factors in Nephrotic Syndrome","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":104,"lead_sponsor_name":"Iain Bressendorff","has_results":false},{"nct_id":"NCT03068572","title":"Diagnostic Value of Linked Color Imaging for Minimal Change Esophagitis in Nonerosive Reflux Esophagitis and GERD","phase":"","overall_status":"UNKNOWN","enrollment_count":90,"lead_sponsor_name":"Affiliated Hospital to Academy of Military Medical Sciences","has_results":false},{"nct_id":"NCT03210688","title":"Active Vitamin D And Reduced Dose Prednisolone for Treatment in Minimal Change Nephropathy","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":71,"lead_sponsor_name":"University of Aarhus","has_results":false},{"nct_id":"NCT05003986","title":"Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":67,"lead_sponsor_name":"Travere Therapeutics, Inc.","has_results":false},{"nct_id":"NCT03298698","title":"Efficacy of Rituximab in Comparison to Continued Corticosteroid Treatment in Idiopathic Nephrotic Syndrome","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"Radboud University Medical Center","has_results":false},{"nct_id":"NCT02592798","title":"Pilot Study to Evaluate the Safety and Efficacy of Abatacept in Adults and Children 6 Years and Older With Excessive Loss of Protein in the Urine Due to Either Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":true},{"nct_id":"NCT05588063","title":"taVNS for FRNS in Children","phase":"NA","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Northwell Health","has_results":false},{"nct_id":"NCT04369183","title":"Rituximab for Refractory or Relapsed Focal Segmental Glomerulosclerosis or Minimal Change Disease","phase":"","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"Istanbul University","has_results":false},{"nct_id":"NCT04235621","title":"A Study to Understand the Genetics and Clinical Course of Focal Segmental Glomerulosclerosis (FSGS), Treatment-Resistant Minimal Change Disease (TR-MCD), and Diabetic Nephropathy (DN)","phase":"","overall_status":"TERMINATED","enrollment_count":20,"lead_sponsor_name":"Goldfinch Bio, Inc.","has_results":false},{"nct_id":"NCT05583942","title":"A Pilot Trial of taVNS for SRNS in Children (kidNEY-VNS)","phase":"NA","overall_status":"RECRUITING","enrollment_count":10,"lead_sponsor_name":"Northwell Health","has_results":false},{"nct_id":"NCT04009668","title":"Tumor Necrosis Factor Inhibition in Focal Segmental Glomerulosclerosis and Treatment Resistant Minimal Change Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":7,"lead_sponsor_name":"University of Michigan","has_results":true},{"nct_id":"NCT05441826","title":"Efficacy and Safety of VB119 in Subjects With Minimal Change Disease (MCD) and Focal Segmental Glomerulosclerosis (FSGS)","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"Tenet Medicines","has_results":false}],"total":18},"guidelines":[],"source":"Drug Landscape verified database"}